{
    "organizations": [],
    "uuid": "d5aa5fc5aeb676b91928715f01506b8f3bd94291",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-boya-bio-pharmaceutical-group-sees/brief-boya-bio-pharmaceutical-group-sees-fy-2018-q1-net-profit-could-rise-up-to-20-pct-idUSL3N1RN37U",
    "ord_in_thread": 0,
    "title": "BRIEF-Boya Bio-pharmaceutical Group sees FY 2018 Q1 net profit could rise up to 20 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10 (Reuters) - Boya Bio-pharmaceutical Group Co Ltd\n* Says it sees FY 2018 Q1 net profit to increase by up to 20 percent, or to be 67.5 million yuan to 80.9 million yuan\n* Says FY 2017 Q1 net profit was 67.5 million yuan\n* Comments that increased income and inclusion of new company as main reasons for the forecast\nSource text in Chinese: goo.gl/k1N7n9\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-10T15:58:00.000+03:00",
    "crawled": "2018-04-11T18:24:32.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "boya",
        "group",
        "co",
        "ltd",
        "say",
        "see",
        "fy",
        "q1",
        "net",
        "profit",
        "increase",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "q1",
        "net",
        "profit",
        "million",
        "yuan",
        "comment",
        "increased",
        "income",
        "inclusion",
        "new",
        "company",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}